Physician profile
Fleming G Brooks
NPI 1992706170
$672.55
in general payments reported to CMS, 2019-2025
11 companies · $40.77 in 2025
The $40.77 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $30.84 · 2021: $232 · 2022: $101 · 2023: $15.37 · 2024: $76.54 · 2025: $40.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $235.15 | 2021-2024 | Pico 14 |
| Tactile Systems Technology INC | $98.09 | 2019 | |
| Bioventus LLC | $93.72 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Heraeus Medical, LLC. | $90.85 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $40.77 | 2025 | Exparel |
| Depuy Synthes Sales INC. | $35.42 | 2020-2021 | |
| Amgen INC. | $23.71 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $15.30 | 2019 | |
| Avanos Medical | $15.15 | 2022 | |
| Pacira Therapeutics, INC. | $13.13 | 2020 | |
| Horizon Therapeutics Plc | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fleming Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.